Action 2342 TRANS GENIC INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Trans Genic Inc.

Actions

2342

JP3635720000

Marché Fermé - Japan Exchange
Autres places de cotation
 08:00:00 26/04/2024 		Varia. 5j. Varia. 1 janv.
248 JPY -5,70 % Graphique intraday de Trans Genic Inc. +10,22 % -4,62 %
2023 Trans Genic Inc. (TSE:2342) annonce un rachat d'actions pour 300.000 actions, représentant 1,78%, pour un montant de 100 millions ¥. CI
2023 Trans Genic Inc. autorise un plan de rachat. CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Tranche Update on Trans Genic Inc.'s Equity Buyback Plan announced on November 22, 2023.
Trans Genic Inc.'s Equity Buyback announced on November 22, 2023, has closed with 300,000 shares, representing 1.78% for ¥78.62 million.
Tranche Update on Trans Genic Inc.'s Equity Buyback Plan announced on November 22, 2023.
Trans Genic Inc. announces an Equity Buyback for 300,000 shares, representing 1.78% for ¥100 million.
Trans Genic Inc. authorizes a Buyback Plan.
Trans Genic Inc. Reports Earnings Results for the Full Year Ended March 31, 2023
Trans Genic Inc. acquired MASC Co., Ltd.
Eurofins Clinical Testing Lux Holding Sarl entered into a share purchase agreement to acquire GeneticLab Co., Ltd. from Trans Genic Inc. for ¥3.2 billion.
Tranche Update on Trans Genic Inc.'s Equity Buyback Plan announced on August 25, 2021.
Trans Genic Inc.'s Equity Buyback announced on August 25, 2021, has closed with 550,000 shares, representing 3.19% for ¥298.6 million.
Trans Genic Inc. completed the acquisition of Lunapas LLC.
Tranche Update on Trans Genic Inc.'s Equity Buyback Plan announced on August 25, 2021.
Trans Genic Inc. entered into share transfer agreement to acquire Lunapas LLC.
Trans Genic Inc. announces an Equity Buyback for 550,000 shares, representing 3.17% for ¥300 million.
Trans Genic Inc. authorizes a Buyback Plan.
Japan's Nikkei dips on investor caution, Topix buoyed by BOJ talk
Medicinal Chemistry Pharmaceuticals,Co.,Ltd. announced that it has received ¥0.08 million in funding from Trans Genic Inc.
Medicinal Chemistry Pharmaceuticals,Co.,Ltd. announced that it expects to receive ¥0.08 million in funding from Trans Genic Inc.
Trans Genic Inc. announced that it has received ¥17.45 million in funding from Merrill Lynch Japan Securities Co., Ltd., Investment Arm
Trans Genic Inc. announced that it expects to receive ¥17.45 million in funding from Merrill Lynch Japan Securities Co., Ltd., Investment Arm
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 2342
  4. Actualités Trans Genic Inc.
  5. Autres langues